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1. Introduction 
Cyclic AMP-dependent protein kinase type I 
(cAKI) and type II (cAKI1) are tetramers composed 
of 2 regulatory (R) and 2 catalytic (C) subunits. R has 
2 types of binding sites for cyclic AMP, one of which 
(A)exchanges its boundcyclic AMP more rapidly than 
the other one (B) [l-3]. Cyclic AMP activates the 
enzyme by promoting its dissociation into a regulatory 
subunit dimer and 2 catalytically active subunits 
(reviews [45]): 
R&a t 4 cyclic AMP 2 Rs cyclic AMP4 t 2 C 
The details of the above reaction are unknown, 
and only recently has enough evidence accumulated 
to decide that cyclic AMP may activate the enzyme 
by binding directly to R in the holoenzyme rather than 
to free R only [5-81. 
This study was undertaken to find if the 2 types of 
binding sites (A en B) that in free RI1 show different 
kinetics in their interaction with cyclic AMP [39] 
also differ functionally in the cAKI1 holoenzyme. For 
this, the time course of the association between cyclic 
[ 3H]AMP and site A and B of cAKI1 holoenzyme 
was monitored. The rate of association was measured 
in the physiologically relevant range (20 nM-2 PM) 
of cyclic AMP concentrations. 
These data suggest hat the site of type A can inter- 
act with cyclic AMP only after the B-site has been 
occupied by the nucleotide. 
2. Experimental 
Adenosine 5’-[y-32P]triphosphate (-2 Ci/mmol) 
was from the Radiochemical Centre, Amersham. Urea 
(analytical grade) was from Merck, and methylamine 
ElsevierjNorth-HoIland Biomedical Press 
from Sigma. Other reagents were from the sources in 
[3,9]. Buffer A is 15 mM Hepes-NaOH(pH 7.0) 
containing 0.3 mM EGTA, 0.1 mM EDTA and 20 mM 
2-mercaptoethanol. 
Buffer B is 62.5 mM Hepes-NaOH (pH 7 .O) con- 
taining 4 M NaCl, 37.5 mM EDTA, 0.5 mM dithio- 
threitol, 20 mM 2-mercaptoethanol, 0.5 mg bovine 
serum albumin/ml and 0.2 mg heat-stable protein frac- 
tion/ml [9]. 
2.1. Preparation of cAKII and RII 
This was as described in [3]. RI1 was eluted from 
the affinity column with urea. 
2.2. Preparation of C 
The catalytic subunit(C) was prepared from bovine 
heart cAKI1 purified through the carboxymethylcellu- 
lose step [3]: 20 ml of cAKII (0.2 PM with respect to 
cyclic AMP binding capacity) was dissociated by incu- 
bation with 0.1 mM cyclic AMP and 0.2 mM 3-iso- 
butyl-1 methylxanthine for 30 mm at O”C, passed 
through a carboxymethylcellulose column (0.9 X 2 cm) 
equilibrated with buffer A and the column washed 
with 10 ml buffer A. The catalytic subunit was then 
eluted with 4 ml buffer A containing 250 mM KC1 
into a tube containing 2 mg albumin in 0.1 ml. The 
concentration of C-subunit was determined by com- 
paring its catalytic efficiency in the phosphotrans- 
ferase assay [lo] with that of preparations of cAKI 
and cAKI1 of known concentrations. 
2.3. cAKiI autophosphorylation 
cAKII(O.2 PM) was incubated in buffer B with 
0.5 mg bovine serum albumin/ml, 10 mM Mg 
(CHa00)2 and 10 @I [y-j2P]ATP (1 /.&i/ml) for 
30 min at O’C. About 1.4 mol 32P was incorporated 
into trichloroacetic acid-precipitable or ammonium 
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sulphate-precipitable protein under those conditions. 
No loss of acid-precipitable or (NH&S04-precipi- 
table 32P occurred under the conditions of the kinetic 
experiments in which the autophosphorylated enzyme 
was used. 
2.4. Association rate studies: Differentiation of cyclic 
/ 3H]AMP bound to site A and B 
Samples (0.1 ml) of cAKI1 in buffer A with 0.15 M 
KC1 were placed in the bottom of plastic tubes. The 
reaction was started by squirting 0.1 ml cyclic 
[3H]AMP in the same buffer into the tube. The reac- 
tion was quenched by the addition of 0.8 ml ice-cold 
buffer B with 0.13 mM unlabelled cyclic AMP. Ali- 
quots (0.17 ml) were removed 0,3.5,6 and 16 h 
(after the addition of quench-solution, and the amount 
of bound isotope determined in the precipitate formed 
by mixing the aliquot with 4 ml 90% satd. ammonium 
sulphate [3]. Since the cyclic [ 3H] AMP associated 
with site A of RI1 exchanges with a half-time of 
30 min under these conditions <2% of the labelled 
nucleotide initially associated with this site remains 
bound after 3.5 h in the quenchsolution [3]. By plot- 
ting the logarithm of the values found for bound cyclic 
[ 3H]AMP after 3 5,6 and 16 h of exchange us time 
and extrapolating to zero time, the amount of cyclic 
[ 3H] AMP bound to site B at the moment of quenching 
could be determined. The amount of nucleotide asso- 
ciated with site A was calculated as total nucleotide 
bound (site A t site B) minus nucleotide bound to 
site B. 
2.5. Plotting of kinetic data 
The association rate constant (k,) for the inter- 
action between cyclic AMP and site A and B was cal- 
culated essentially as in [ 111. For site A: 
1 
ka*t= [A]o-([L]o- [B-L],) 
ln([Llo- P -Llr) .([Alo - P-L],) 
[A],.([L],- IB.L],- ]A.Ll,) 
For the calculation of k, for site B, A and B should 
be interchanged in all the terms above: [A], , total 
concentration of cyclic AMP binding sites of type A; 
[L],, total concentration of cyclic AMP; [B . L], 
and [A . L] t, concentration of cyclic AMP complexed 
to site B and A, respectively, after a certain time of 
reaction. 
3. Results 
3.1. On the reliability of the methods used to study 
the rate of association to site A and B of cAKII 
To have an idea of the precision obtained with the 
manual mixing procedure six parallel determinations 
of bound cyclic AMP were performed ‘immediately’ 
after the association reaction was stated, after -0.5 s 
and after 1,2 and 3 s of reaction. When the concentra- 
tions of cyclic [3H]AMP and binding protein (RI1 or 
cAKI1) were adjusted so that the amount bound after 
1 s of reaction was at least twice the blank values of 
the assay, the range of values for bound nucleotide 
determined were within +40% of the mean for 0.5 s, 
*25% for 1 s and *15% for 2 s and 3 s of reaction. The 
mean value for the amount of nucleotide ‘immediately’ 
bound was l/ 10th that after 1 s of reaction, suggesting 
that the lag involved in quenching the reaction was 
<O.l s. 
To ensure that the xchange reaction used to dif- 
ferentiate cyclic [3H]AMP bound to site A and B was 
unaffected by the various conditions used during the 
association reaction, detailed exchange rate studies 
were performed at 0°C and 30°C for various concen- 
trations (0.4-30 nM) of autophosphorylated and non- 
phosphorylated cAKI1 saturated to various degrees 
with cyclic [3H]AMP. The slopes of neither the rapid 
nor the slow phase of exchange were affected by the 
concentrations or degree of saturation of cAKI1 at 
either temperature. The presence of 20 nM of the 
catalytic subunit of protein kinase did not alter the 
exchange rates. 
It should be noted that the xcess unlabelled cyclic 
AMPin the quench solution served not only to quench 
the association rate by isotope dilution, but also to 
dissociate cAKI1 into subunits. The RI1 cyclic [3H]- 
AMP in the quench-solution existed thus in the free 
form. A final point of concern was, however, that 
cyclic [3H] AMP bound in a putative ternary complex 
with C and R might be perturbed in the interval 
between the addition of quench-solution and the com- 
plete dissociation of cAKI1 into subunits. It was rea- 
soned that this interval would be shorter at high con- 
centrations of cyclic AMP, and that any perturbation 
would be more pronounced at low than at high con- 
centrations of cyclic AMP in the quench-solution. In 
an experiment like that of fig. 1 a the reactions were 
quenched by the addition of 0.2 ml of 20 /JM or 
20 n-&l cyclic AMP in buffer A with 0.15 M KCl, and 
then 1.6 ml buffer B with 0.13 mM cyclic AMP added. 
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Fig.1 . Association of cyclic [“H] AMP and cAKI1. Cyclic AMP and cAKI1 were reacted for the periods of time indicated on the 
abscissa, and the amount of nucleotide bound to site A (m) and site B (o) determined. k, . t was calculated as explained in section 
2: (a) cyclic [‘HIAMP was 30 nM, cAKI1 binding sites 6 nM; (b) cyclic [3H]AMP was 0.6 PM, cAKI1 binding sites 20 r&I. 
The results were the same within experimental error 
whether the reactions were quenched with 20 PM or 
20 mM cyclic AMP in 0.15 M KC1 or as in section 2 
(0.13 mM cyclic AMP in buffer B). It seems thus that 
the method used gives a true estimate of the amount 
of cyclic [jH] AMP bound to cAKlI at the moment of 
quenching. 
3.2. Kinetics of the initial phase of association of 
cyclic AMP pnd cAKZZ 
The time course of association at O’C in 0.15 M 
KCl is shown in fg.12. An initial burst was observed 
for the rate of occupancy of site B by cyclic AMP and 
a corresponding lag for site A. There was no significant 
difference in association rate between autophospho- 
rylated and nonphosphorylated cAKl1 (fig.2). Further- 
more, cAKl1 preincubated at 37’C for 10 min with 
10 mM Mg-acetate/S mM ATP, and incubated with 
2 mM Mg-acetate/O.l mM ATP showed kinetics similar 
to that of enzyme treated similarly, but not exposed 
to ATP during preincubation and incubation. 
5 15 25 
The of assocmtlon (sod 
Fig.2. Comparison of association rate of cyclic [3H] AMP to 
untreated and autophosphorylated cAKI1. The time course of 
binding (expressed as k, . t to site A (m) and site B (0) of un- 
treated, and to site A (A) and site B (A) of autophosphorylated 
cAKI1 is shown: cyclic ['HI AMP Was 0.1 NM, cA%II binding 
sites 10 nM. 
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The initial nonlinear kinetics of binding was more 
easily studied at low concentrations of cyclic AMP 
(fig.la), the reaction proceeding too fast at higher 
concentrations (fig.lb) to be monitored with manual 
mixing. The pattern was independent of enzyme con- 
centration from 2-20 nM, indicating that liberation 
of free C was not responsible for the burst and lag for 
binding to site B and A, respectively. 
3.3. Kinetics of the second phase of association of 
cyclic AMP and cAKII ’ 
After the initial nonlinear phase of binding, most 
evident at the lower concentrations of cyclic AMP 
tested (frg.la,2), the binding to site A and B proceeded 
at a near linear rate for some time. The apparent asso- 
ciation rate constant (k,) of this phase was higher at 
high than at low concentrations of cyclic AMP. The 
k, thus increased from -lo4 M-' . s-’ at 20 nM cyclic 
AMP to -8 X lo4 M-r. s-l at 2 PM cyclic AMP when 
incubations were at 0°C in 0.15 M KCl. 
To find if k, varied also at a physiological temper- 
ature and in the physiologically relevant range of 
cyclic AMP concentrations, association rate studies 
were performed at 37°C in 0.15 M KC1 with 0.5 PM 
and 2 I.IM cyclic AMP. The linear phase of cyclic AMP 
accumulation was shorter than at 0°C presumably 
due to a substantial C-induced dissociation of the 
RR-cyclic AMP complex at 37°C. The k, at 2 nM 
cyclic AMP (-3.5 X 10’ M-' . s-l) and at 0.5 PM 
cyclic AMP (-2 X 10’ M-’ . s-l) was nevertheless 
determined with sufficient precision to conclude that 
k, increased with cyclic AMP concentration also at 
37°C. 
4. Discussion 
Some aspects of the interaction between cyclic 
AMP and site A and B of the free regulatory moiety 
(RR) of protein kinase II (cAKI1) were presented in 
[9]. The nucleotide bound more rapidly to site A than 
to site B of the free RII, the initial rate of accumula- 
tion to either site was linear, and the apparent associ- 
ation rate constant (k,) was independent of the con- 
tration of cyclic AMP [9]. 
The initial phase of cyclic AMP binding to the 
cAKI1 holoenzyme wasmore complex (fig.l,2). Thus, 
there was a burst of cyclic AMP binding to site B and 
a corresponding lag for the binding to site A. This 
suggests that in the ground state of cAKI1 only site B 
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is free to react with cyclic AMP, and that binding to 
site B alters the conformation of cAKI1 so that also 
site A may react with cyclic AMP. 
In [ 11,121 the time course of the accumulation of 
cyclic AMP occurring after >l min incubation with 
endometrial cAK was shown. These data strongly sug- 
gest that an initial burst of binding must have occurred 
during the first 1 min incubation. It is of special inter- 
est that the millipore filtration method used in [ 11 ,121 
seems to detect only binding to site B of cAK [3], 
which is the site showing a burst of accumulation here 
(flg.l,2). 
After the initial nonlinear phase the accumulation 
of cyclic AMP to site A and B of cAKI1 proceeded 
near linearly and at a similar rate for the 2 sites (fig. 
1,2). The apparent k, calculated for this phase of the 
association increased as a function of the cyclic AMP 
concentration. These observations suggest hat the 
complex between the first molecule of cyclic AMP 
bound and site B of cAKI1 is unstable, being stabilized 
by the binding of further molecules of cyclic AMP to 
cAKI1. The stabilization of the binding of cyclic AMP 
may correspond to the dissociation of one or both of 
the C-subunits from the cAKI-cyclic AMP complex. 
The kinetic data obtained for the interaction between 
cyclic AMP and an insect protein kinase of composi- 
tion CR was found to fit the model: 
CR + cyclic AMP 2 CR-cyclic AMP 2 R-cyclic AMP + C 
where the cyclic AMP dissociates much more rapidly 
from the ternary complex than from the R-cyclic 
AMP complex [7]. For the mammalian tetrameric 
kinase with 4 binding sites the kinetic analysis is more 
complex. Thus, after one of the B-sites of cAKI1 has 
been occupied there are 6 possible sequences for bind- 
ing to the 3 remaining sites (fig.3). To find which of 
the sequences is the preferred one(s), and at what 
points in the sequence the catalytic subunits become 
active will require more detailed kinetic studies pref- 
erably using cyclic AMP analogues with a high degree 
of preference for site A or B. To establish the true 
sequence and determine to what degree the interme- 
diary complexes accumulate may be of more than 
theoretical interest, since it has been suggested that 
some intermediary complex of cAKI1 and cyclic AMP 
rather than the ground state of the holoenzyme or 
the fully saturated RI1 is transported across the nuclear 
membrane [ 13,141. 
One of the important features of the cyclic AMP- 
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AbAB aBAB ABaB 
\ 1 i 
ABAB 
Fig.3. The possible sequences of cyclic AMP binding to cAKI1 
with one B-site occupied are shown. Occupied sites are indi- 
cated with capital letters. That only the forward reaction 
has been indicated (-) does not imply that the steps are 
irreversible. 
dependent protein kinases is their ability to be signif- 
icantly activated in vivo in response to a very slight 
increase of the intracellular concentration f cyclic 
AMP, the in vivo binding of cyclic AMP showing 
apparent positive cooperativity (discussed in [5,15]). 
One mechanism responsible for this apparent posi- 
tive cooperativity is presumably the increasing retarda- 
tion of the reassociation of R and C subunits when 
the concentration of cyclic AMP is increased within 
the physiological range [S]. Another mechanism may 
be the increase of the apparent k, for the association 
between cyclic AMP and cAKI1 noted here when the 
concentration of cyclic AMP was increased. This in- 
crease was evident at a physiological temperature, pH 
and ionic strength and in the physiologically relevant 
range of cyclic AMP concentrations. 
There is evidence that cAKI1 exists mainly in a 
phosphorylated form in freshly prepared extracts of 
bovine cardiac muscle. By exposing the enzyme to 
phosphatases (deliberately or during lengthy purifica- 
tion procedures) it is converted to a form that readily 
accepts the terminal phosphate of ATP in an autophos- 
phorylation reaction [ 161. 
The unusual kinetics of the association of cyclic 
AMP and cAKII noted here may be due to heteroge- 
neity in the content of endogenous phosphate at the 
autophosphorylable site(s). The fully autophospho- 
rylated cAKI1, presumed to be the predominating form 
in vivo [ 161, might show kinetics different from those 
here. However, the similar rate of cyclic AMP accu- 
mulation to untreated cAKI1 and cAKI1 exposed to 
conditions favourable for autophosphorylation (fig.2), 
rendered those possibilities unlikely. 
According to [ 171 each RI1 subunit contains 
22 mol of phosphate. About 1.4 mol phosphate was 
transferred to the RI1 subunit during the autophos- 
phorylation reaction (see section 2). It is therefore 
possible that our preparation of cAKI1 contained 
endogenous phosphate, and that the completely de- 
phosphorylated cAKI1 might have kinetic properties 
distinct from those described here. 
The interaction with cyclic AMP is different for 
site A and B when in the cAKI1 holoenzyme than 
when in free RII. The contention that cyclic AMP 
may interact directly with cAK holoenzyme and not 
only with free R is thus supported. The initial burst 
of cyclic AMP binding to site B and lag in binding to 
site A suggest hat only site B is free to react with 
cyclic AMP in the cAKI1 holoenzyme, and that bind- 
ing to site A occurs after site B has been occupied. 
The finding that the rate of cyclic AMP binding to 
cAKI1 increased more than proportionally to the cyclic 
AMP concentration may be of relevance to explain 
the apparent positive cooperativity observed for the 
binding of cyclic AMP to cAK in vivo [5,15]. 
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